Sugi Predict

Sugi Predict / Compounds / SCHEMBL13488524

SCHEMBL13488524

SCHEMBL13488524

CCCCCC/C=C\CCCCCCCCCC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](OP(=O)(O)O)[C@H](NC(=O)CC(=O)CCCCCCCCCCC)[C@@H](OCCCCCCCCCC)[C@@H]2O)O[C@H](COC)[C@@H](OP(=O)(O)O)[C@@H]1OCCC(O)CCCCCCC

nearest known ligand 0.87

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TLR4 O00206 19/20 0.87
▸ LY96 Q9Y6Y9 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488523 0.97 TLR4 (0.81) TLR4LY96
SCHEMBL13488526 0.96 TLR4 (0.80) TLR4LY96
SCHEMBL13488521 0.94 TLR4 (0.78) TLR4LY96
Eritoran SCHEMBL12836754 0.93 TLR4 (1.00) TLR4LY96
Eritoran SCHEMBL12371609 0.93 TLR4 (1.00) TLR4LY96
Eritoran SCHEMBL10042160 0.93 TLR4 (1.00) TLR4LY96
Eritoran SCHEMBL13302901 0.93 TLR4 (1.00) TLR4LY96
Eritoran SCHEMBL10042165 0.93 TLR4 (1.00) TLR4LY96
Eritoran SCHEMBL21378839 0.93 TLR4 (1.00) TLR4LY96
Eritoran SCHEMBL14081112 0.93 TLR4 (1.00) TLR4LY96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012410-B2 Method of treating intrauterine inflammation CASE WESTERN RESERVE UNIVERSITY (US) 2015-04-21 — — US disclosed
US-20100035829-A1 METHOD OF TREATING INTRAUTERINE INFLAMMATION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035829-A1 METHOD OF TREATING INTRAUTERINE INFLAMMATION TLR4, TLR2, TLR3 TLR4 1/4885LY96 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.